Editas Medicine (EDIT) Common Equity (2015 - 2025)
Editas Medicine (EDIT) posted Common Equity of $27.29 million for Q4 2025, down 79.7% from $134.27 million a year earlier but up 102.8% from the prior quarter.
Analysis
Editas Medicine (EDIT) Common Equity (2015 - 2025) Analysis & Trends
Since Q4 2015, Editas Medicine has reported Common Equity for 41 quarters.
- Annual Common Equity has declined for four consecutive years, with a five-year compound annual growth rate of -41.4% (FY2020 to FY2025).
- In prior years, Editas Medicine's Common Equity was $134.27 million in FY2024 (-61.5%), $349.1 million in FY2023 (-3.2%), $360.68 million in FY2022 (-34.9%) and $553.64 million in FY2021 (+40.7%).
- Quarterly Common Equity has run from a low of $13.45 million in Q3 2025 to a high of $638 million in Q1 2021 over five years.
- On a year-over-year basis, Common Equity has declined in each of the last 16 quarters, with an average decline of 63.1% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q1 2021, with growth of 172.0%; the weakest was Q3 2025, with a decline of 92.3%.
- According to Business Quant data, Common Equity for the three prior quarters was $13.45 million (Q3 2025), $19.19 million (Q2 2025) and $62.42 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Editas Medicine | 234.09 Mn | -477.66 Mn | - | 27.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 27.29 Mn |
| Sep 30, 2025 | 13.45 Mn |
| Jun 30, 2025 | 19.19 Mn |
| Mar 31, 2025 | 62.42 Mn |
| Dec 31, 2024 | 134.27 Mn |
| Sep 30, 2024 | 175.63 Mn |
| Jun 30, 2024 | 232.01 Mn |
| Mar 31, 2024 | 294.40 Mn |
| Dec 31, 2023 | 349.10 Mn |
| Sep 30, 2023 | 360.46 Mn |
| Jun 30, 2023 | 399.92 Mn |
| Mar 31, 2023 | 317.47 Mn |
| Dec 31, 2022 | 360.68 Mn |
| Sep 30, 2022 | 414.75 Mn |
| Jun 30, 2022 | 465.41 Mn |
| Mar 31, 2022 | 512.76 Mn |
| Dec 31, 2021 | 553.64 Mn |
| Sep 30, 2021 | 586.79 Mn |
| Jun 30, 2021 | 613.36 Mn |
| Mar 31, 2021 | 638.00 Mn |
API Access
Editas Medicine Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=EDIT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();